Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study
Author(s):
Weinblatt, M.; Fleischmann, R.M.; Vollenhoven, R.F. van; Emery, P.; Huizinga, T.W.J. (0000-0001-7033-7520); Cutolo, M.; Goldermann, R.; Duncan, B.; Davies, O.; Dougados, M.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-10-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 10, p. S490-S491
